Login / Signup

Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds.

Bruno RizzutiLaura Ceballos-LaitaDavid Ortega-AlarconAna Jimenez-AlesancoSonia VegaFedora GrandeFilomena ConfortiOlga AbiánAdrián Velázquez-Campoy
Published in: Pharmaceuticals (Basel, Switzerland) (2021)
Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (Ki = 0.81 μM). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (Ki = 4.1 μM), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW < 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • neoadjuvant chemotherapy
  • signaling pathway
  • hydrogen peroxide
  • squamous cell carcinoma
  • transcription factor
  • dna binding
  • lymph node
  • rectal cancer